Neurocrine Biosciences, Inc. Share Price
Equities
NBIX
US64125C1099
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
136.2 USD | -0.40% | -3.92% | +3.33% |
Sales 2024 * | 2.22B 185B | Sales 2025 * | 2.54B 212B | Capitalization | 13.7B 1,144B |
---|---|---|---|---|---|
Net income 2024 * | 439M 36.66B | Net income 2025 * | 666M 55.61B | EV / Sales 2024 * | 5.27 x |
Net cash position 2024 * | 2B 167B | Net cash position 2025 * | 2.79B 233B | EV / Sales 2025 * | 4.29 x |
P/E ratio 2024 * |
32.7
x | P/E ratio 2025 * |
21.5
x | Employees | 1,448 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.73% |
Latest transcript on Neurocrine Biosciences, Inc.
1 day | -0.40% | ||
1 week | -3.92% | ||
Current month | -1.01% | ||
1 month | +1.11% | ||
3 months | +1.73% | ||
6 months | +23.49% | ||
Current year | +3.33% |
Managers | Title | Age | Since |
---|---|---|---|
Kevin Gorman
FOU | Founder | 66 | 01/92/01 |
Director of Finance/CFO | 44 | 01/17/01 | |
Jude Onyia
CTO | Chief Tech/Sci/R&D Officer | 60 | 30/21/30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Stephen Sherwin
BRD | Director/Board Member | 75 | 01/99/01 |
George Morrow
BRD | Director/Board Member | 72 | 01/15/01 |
Kevin Gorman
FOU | Founder | 66 | 01/92/01 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
13.65% | 254 M€ | +11.45% | - | |
3.81% | 1 M€ | -2.17% | - | |
1.85% | 8 M€ | +4.88% | ||
1.08% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
13/24/13 | 136.2 | -0.40% | 669,376 |
10/24/10 | 136.7 | -2.12% | 679,327 |
09/24/09 | 139.7 | +0.46% | 479,494 |
08/24/08 | 139 | -2.91% | 653,668 |
07/24/07 | 143.2 | +1.04% | 667,258 |
Delayed Quote Nasdaq, May 14, 2024 at 01:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.33% | 13.76B | |
+5.66% | 109B | |
+11.23% | 105B | |
-0.38% | 22.25B | |
-12.15% | 22.09B | |
-7.66% | 18.68B | |
-36.52% | 17.58B | |
-10.09% | 16.85B | |
+36.58% | 12.46B | |
+288.77% | 8.12B |
- Stock Market
- Equities
- NBIX Stock